Year |
Citation |
Score |
2024 |
Huang P, Ho CK, Cao D, Inan S, Rawls SM, Li M, Huang B, Pagare PP, Townsend EA, Poklis JL, Halquist MS, Banks M, Zhang Y, Liu-Chen LY. . The Journal of Pharmacology and Experimental Therapeutics. PMID 38409113 DOI: 10.1124/jpet.123.001870 |
0.446 |
|
2023 |
Barrett JE, Shekarabi A, Inan S. . Pharmacological Reviews. PMID 37321860 DOI: 10.1124/pharmrev.121.000506 |
0.4 |
|
2022 |
Kim BS, Inan S, Ständer S, Sciascia T, Szepietowski J, Yosipovitch G. The Role of Kappa-Opioid and Mu-Opioid Receptors in Pruritus: Peripheral and Central Itch Circuits. Experimental Dermatology. PMID 36054458 DOI: 10.1111/exd.14669 |
0.388 |
|
2022 |
Bongiovanni AR, Zhao P, Inan S, Wiah S, Shekarabi A, Farkas DJ, Watson MN, Wimmer ME, Ruff MR, Rawls SM. Multi-chemokine receptor antagonist RAP-103 inhibits opioid-derived respiratory depression, reduces opioid reinforcement and physical dependence, and normalizes opioid-induced dysregulation of mesolimbic chemokine receptors in rats. Drug and Alcohol Dependence. 238: 109556. PMID 35843139 DOI: 10.1016/j.drugalcdep.2022.109556 |
0.442 |
|
2022 |
Ruff MR, Inan S, Shi XQ, Meissler JJ, Adler MW, Eisenstein TK, Zhang J. Potentiation of morphine antinociception and inhibition of diabetic neuropathic pain by the multi-chemokine receptor antagonist peptide RAP-103. Life Sciences. 306: 120788. PMID 35817166 DOI: 10.1016/j.lfs.2022.120788 |
0.368 |
|
2021 |
Inan S, Chen X, Eisenstein EM, Meissler JJ, Geller EB, Tallarida C, Watson M, Doura M, Barrett JE, Cowan A, Rawls SM, Adler MW, Eisenstein TK. Chemokine receptor antagonists enhance morphine's antinociceptive effect but not respiratory depression. Life Sciences. 120014. PMID 34619167 DOI: 10.1016/j.lfs.2021.120014 |
0.405 |
|
2021 |
Inan S, Chen X, Eisenstein EM, Meissler JJ, Geller EB, Tallarida C, Watson M, Doura M, Barrett JE, Cowan A, Rawls SM, Adler MW, Eisenstein TK. Chemokine receptor antagonists enhance morphine's antinociceptive effect but not respiratory depression. Life Sciences. 120014. PMID 34619167 DOI: 10.1016/j.lfs.2021.120014 |
0.405 |
|
2021 |
Inan S, Dun NJ, Cowan A. Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic. Molecules (Basel, Switzerland). 26. PMID 34576988 DOI: 10.3390/molecules26185517 |
0.57 |
|
2021 |
Inan S. Kappa Opioid Agonist-Induced Diuresis: Characteristics, Mechanisms, and Beyond. Handbook of Experimental Pharmacology. PMID 33483878 DOI: 10.1007/164_2020_399 |
0.353 |
|
2020 |
Inan S, Cowan A. Antipruritic Effects of Kappa Opioid Receptor Agonists: Evidence from Rodents to Humans. Handbook of Experimental Pharmacology. PMID 33296031 DOI: 10.1007/164_2020_420 |
0.363 |
|
2020 |
Wang M, Irvin TC, Herdman CA, Hanna RD, Hassan SA, Lee YS, Kaska S, Crowley RS, Prisinzano TE, Withey SL, Paronis CA, Bergman J, Inan S, Geller EB, Adler MW, et al. The Intriguing Effects of Substituents in the -Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of "Tail Wags Dog" Experiments. Molecules (Basel, Switzerland). 25. PMID 32517185 DOI: 10.3390/Molecules25112640 |
0.469 |
|
2020 |
Eisenstein TK, Chen X, Inan S, Meissler JJ, Tallarida CS, Geller EB, Rawls SM, Cowan A, Adler MW. Chemokine Receptor Antagonists in Combination with Morphine as a Novel Strategy for Opioid Dose Reduction in Pain Management. Military Medicine. 185: 130-135. PMID 32074321 DOI: 10.1093/Milmed/Usz320 |
0.509 |
|
2019 |
Inan S, Huerta AT, Jensen LE, Dun NJ, Cowan A. Nalbuphine, a kappa opioid receptor agonist and mu opioid receptor antagonist attenuates pruritus, decreases IL-31, and increases IL-10 in mice with contact dermatitis. European Journal of Pharmacology. 172702. PMID 31568781 DOI: 10.1016/J.Ejphar.2019.172702 |
0.597 |
|
2019 |
Chen X, Cowan A, Inan S, Geller EB, Meissler JJ, Rawls SM, Tallarida RJ, Tallarida CS, Watson MN, Adler MW, Eisenstein TK. Opioid-Sparing Effects of Cannabinoids on Morphine Analgesia: Participation of CB1 and CB2 Receptors. British Journal of Pharmacology. PMID 31218677 DOI: 10.1111/Bph.14769 |
0.482 |
|
2019 |
Inan S, Watson MN, Doura M, Tallarida CS, Meissler JJ, Chen X, Geller EB, Cowan A, Rawls SM, Eisenstein TK, Adler MW. Chemokine receptor antagonists enhance the antinociceptive activity of oxycodone and meperidine on incisional pain in rats. British Journal of Anaesthesia. PMID 30916010 DOI: 10.1016/J.Bja.2019.01.021 |
0.417 |
|
2018 |
Inan S, Eisenstein TK, Watson MN, Doura M, Meissler JJ, Tallarida CS, Chen X, Geller EB, Rawls SM, Cowan A, Adler MW. Co-Administration of Chemokine Receptor Antagonists with Morphine Potentiates Morphine's Analgesic Effect on Incisional Pain in Rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 30249618 DOI: 10.1124/Jpet.118.252890 |
0.5 |
|
2015 |
Cowan A, Kehner GB, Inan S. Targeting Itch with Ligands Selective for κ Opioid Receptors. Handbook of Experimental Pharmacology. 226: 291-314. PMID 25861786 DOI: 10.1007/978-3-662-44605-8_16 |
0.463 |
|
2011 |
Inan S, Dun NJ, Cowan A. Investigation of gastrin-releasing peptide as a mediator for 5'-guanidinonaltrindole-induced compulsive scratching in mice. Peptides. 32: 286-92. PMID 21126550 DOI: 10.1016/J.Peptides.2010.11.022 |
0.628 |
|
2009 |
Inan S, Dun NJ, Cowan A. Inhibitory effect of lidocaine on pain and itch using formalin-induced nociception and 5'-guanidinonaltrindole-induced scratching models in mice: behavioral and neuroanatomical evidence. European Journal of Pharmacology. 616: 141-6. PMID 19549515 DOI: 10.1016/J.Ejphar.2009.06.026 |
0.579 |
|
2009 |
Inan S, Dun NJ, Cowan A. Nalfurafine prevents 5'-guanidinonaltrindole- and compound 48/80-induced spinal c-fos expression and attenuates 5'-guanidinonaltrindole-elicited scratching behavior in mice. Neuroscience. 163: 23-33. PMID 19524022 DOI: 10.1016/J.Neuroscience.2009.06.016 |
0.612 |
|
2009 |
Inan S, Lee DY, Liu-Chen LY, Cowan A. Comparison of the diuretic effects of chemically diverse kappa opioid agonists in rats: nalfurafine, U50,488H, and salvinorin A. Naunyn-Schmiedeberg's Archives of Pharmacology. 379: 263-70. PMID 18925386 DOI: 10.1007/S00210-008-0358-8 |
0.447 |
|
2007 |
Brailoiu GC, Dun SL, Brailoiu E, Inan S, Yang J, Chang JK, Dun NJ. Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology. 148: 5088-94. PMID 17627999 DOI: 10.1210/En.2007-0701 |
0.488 |
|
2006 |
Inan S, Cowan A. Nalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in rats. Pharmacology, Biochemistry, and Behavior. 85: 39-43. PMID 16919318 DOI: 10.1016/J.Pbb.2006.07.004 |
0.492 |
|
2005 |
Inan S, Cowan A. Reduced kappa-opioid activity in a rat model of cholestasis. European Journal of Pharmacology. 518: 182-6. PMID 16054619 DOI: 10.1016/J.Ejphar.2005.06.025 |
0.426 |
|
2005 |
Rawls SM, Hewson JM, Inan S, Cowan A. Brain delta2 opioid receptors mediate SNC-80-evoked hypothermia in rats. Brain Research. 1049: 61-9. PMID 15936000 DOI: 10.1016/J.Brainres.2005.04.074 |
0.49 |
|
2005 |
Zhang N, Inan S, Inan S, Cowan A, Sun R, Wang JM, Rogers TJ, Caterina M, Oppenheim JJ. A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1. Proceedings of the National Academy of Sciences of the United States of America. 102: 4536-41. PMID 15764707 DOI: 10.1073/Pnas.0406030102 |
0.329 |
|
2005 |
Wang Y, Tang K, Inan S, Siebert D, Holzgrabe U, Lee DY, Huang P, Li JG, Cowan A, Liu-Chen LY. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo. The Journal of Pharmacology and Experimental Therapeutics. 312: 220-30. PMID 15383632 DOI: 10.1124/Jpet.104.073668 |
0.477 |
|
2004 |
Inan S, Cowan A. Kappa opioid agonists suppress chloroquine-induced scratching in mice. European Journal of Pharmacology. 502: 233-7. PMID 15476749 DOI: 10.1016/J.Ejphar.2004.09.010 |
0.522 |
|
2004 |
Inan S, Tallarida RJ. Morphine potentiates dextromethorphan-induced vasodilation in rat superior mesenteric artery. European Journal of Pharmacology. 486: 61-5. PMID 14751409 DOI: 10.1016/J.Ejphar.2003.12.010 |
0.371 |
|
2004 |
Zhang N, Inan S, Cowan A, Guler A, Sun R, Wang J, Rogers T, Caterina M, Oppenheim J. Arthritis Research & Therapy. 6: 16. DOI: 10.1186/Ar1350 |
0.438 |
|
Show low-probability matches. |